bioRxiv / medRxivopen access
A novel pan class-I glucose transporter inhibitor DRB18 exhibits synergistic effects in vitro and in vivo with paclitaxel against human non-small cell lung cancer
cancer biology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 619182
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.